Transforming Gene Therapy with Safer Alternatives
Infirmacea is redefining the future of health through innovative advances in gene therapy. Our commitment to developing safer, more adaptable technologies not only addresses the limitations of current approaches but also shifts the paradigm—making gene therapy broadly applicable as a practical, long-term solution. With our ultrasafe DNA platform, we aim to extend gene therapy beyond rare diseases, with the ultimate goal of enabling preventive care for age-related conditions and bringing genomic medicine closer to routine clinical practice.
Mission: Revitalizing Aging
Infirmacea’s mission is to extend healthy lifespans. Inspired by the Latin infirmus (weak) and the Greek akos (acea; cure), we are dedicated to addressing the urgent healthcare challenges of an aging global population.
Through our breakthrough DNA-based gene therapy platform, we are expanding the boundaries of what gene therapy can achieve—moving beyond the confines of rare genetic diseases toward general, chronic and age-related conditions. Our long-term vision is to enable people to age with health and vitality, free from preventable disease, and to help build a more sustainable and resilient society through innovation in advanced therapeutics.
Business Model: Gene Therapy Solution Provider
Infirmacea operates on two core business pillars. First, we license our proprietary gBoost™ platform—a breakthrough technology that enhances gene expression across both viral and non-viral delivery systems—enabling partners to unlock the full potential of their gene therapies. Second, we drive drug development by establishing start-ups in leading global bio-innovation hubs. Our initial focus is on therapeutic protein production through DNA therapy, delivering safe and accessible treatments to address unmet medical needs. As we advance, our goal is to expand beyond protein production further broadening the therapeutic applications of our platform. These complementary pillars position Infirmacea to support and advance innovative gene therapy solutions across diverse applications. For technical details and license/partnership opportunities, please visit the gBoost™ section.
Product: Maximize Your Gene Therapy with gBoostTM
Our breakthrough technology, gBoost™, unlocks the full potential of gene therapy by significantly enhancing gene expression across both viral and non-viral delivery systems. By boosting gene expression, gBoost™ can improve therapeutic efficacy and enable the development of safer, more cost-effective viral gene therapy products. For non-viral applications—where low gene expression has traditionally limited therapeutic use—gBoost™ overcomes this barrier, making DNA-based therapies a viable option for a broader range of indications. No matter which delivery platform you choose, gBoost™ elevates the performance of your gene therapy, serving as a transformative tool to advance therapeutic outcomes. For detailed technical insights, please visit the gBoostTM section.
